News | June 22, 2022
Briefs: Marksans Pharma and Alkem
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
The US FDA had conducted an inspection of Alkem Laboratories Limited's manufacturing facility located at St. Louis, USA.
Marksans Pharma has reported consolidated financial results for the period ended December 31, 2021
The shareholders have also ratified the Board’s approval to allot 10 lakhs warrants to the Promoter, Managing Director and CEO, Mark Saldanha at the said price of Rs. 74 per warrant
The company's operating revenue for Q4 FY21 was Rs. 330.2 crore
The Subsidiary has received one inspectional observation in Form 483
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Emcure Pharmaceuticals API facility
Relonchem Limited has received Marketing Authorization for the product Levonorgestrel 1.5 mg Tablets from UK MHRA
Alembic Pharmaceuticals receives 11 USFDA product approval during Q1 FY2025
Gross profit was Rs. 313.3 crore, up by +30.4% YoY with a Gross margin of 53.5%
Subscribe To Our Newsletter & Stay Updated
